Browning J D, Dick H M, Sturrock R, Grennan D, Dick W C
Scott Med J. 1979 Jan;24(1):5-8. doi: 10.1177/003693307902400102.
Sixty-eight patients with various connective tissue disorders, 5 relatives of patients and 26 members of staff from the Centre for Rheumatic Diseases were studied for the presence in their sera of cold lymphocytotoxic antibodies. Antibodies were found in 71 percent of patients with systemic lupus erythematosus, 27 per cent of patients with rheumatoid arthritis, 0 per cent of the small group of relatives and 3.8 per cent of the controls. Absorption studies did not show T or B specificity of the antibodies. The control group, working in close proximity to the patients or their sera did not show any increased incidence of antibodies as compared to control groups of other studies. Red blood cell anti I or HI was found in the sera of 28 per cent of those with cold lymphocytotoxic antibodies. No correlation was found between the presence of the antibodies and number of blood transfusions or pregnancies, increasing age, R3 titre or antinuclear factor.
对68名患有各种结缔组织疾病的患者、5名患者亲属以及26名来自风湿病中心的工作人员进行了研究,以检测他们血清中是否存在冷淋巴细胞毒性抗体。在系统性红斑狼疮患者中,71%的患者血清中发现了抗体;类风湿性关节炎患者中,27%的患者血清中发现了抗体;一小部分亲属中,抗体阳性率为0%;对照组中,抗体阳性率为3.8%。吸收研究未显示抗体具有T或B特异性。与其他研究的对照组相比,在与患者或其血清密切接触的环境中工作的对照组,抗体发生率并未增加。在28%的冷淋巴细胞毒性抗体阳性者的血清中发现了红细胞抗I或抗HI。未发现抗体的存在与输血次数、妊娠次数、年龄增长、R3滴度或抗核因子之间存在相关性。